Registrational assay menu

We offer a broad range of investigation ready assays supported in our CAP/CLIA lab, which includes many important emerging biomarkers. Our capabilities are ever-evolving, so if you don’t see your biomarker of interest here, just ask.

 

BIOMARKER TECHNOLOGY MULTIPLEX
ALK IHC
Bcl-2 IHC
CD30  IHC
CLDN18 IHC
c-MET IHC
c-Myc IHC
EGFR PCR
HA (Hyaluronic Acid) IHC
HER2 IHC
HER2 Dual ISH ISH
HER3 IHC
LIV-1 IHC
MMR Panel IHC
p16 IHC
PD-L1 (SP142) IHC
PD-L1 (SP263) IHC
PTEN IHC
TROP2 IHC

Why Digital Pathology?

CDx assays are answering more complex questions than ever before. Our fully integrated uPath solution for digital pathology (DP) delivers new value for patients, bolstering clinical decision-making by allowing pathologists to analyze confidently. Because DP provides additional information that helps to enable precise diagnosis and identify more of your patient population, integration of an algorithm into your strategy stretches your CDx collaboration further.